Aurora Cannabis Buys U.K. Importer and Pharmacy to Deepen Medical Cannabis Reach
TipRanks (Wed, 19-Aug 2:47 PM ET)
PRNewswire (Wed, 19-Aug 1:46 PM ET)
Aurora Cannabis confirms Curaleaf hostile takeover bid
Seeking Alpha News (Wed, 19-Aug 8:11 AM ET)
Aurora Cannabis shareholders urged to wait on Curaleaf bid
Seeking Alpha News (Wed, 19-Aug 8:06 AM ET)
Aurora Cannabis Tells Investors to Sit Tight as Curaleaf Launches Hostile Bid
TipRanks (Wed, 19-Aug 7:47 AM ET)
PRNewswire (Wed, 19-Aug 7:05 AM ET)
M&A News: Aurora Cannabis Stock (ACB) Rises on $260 Million Takeover Bid
TipRanks (Tue, 18-Aug 2:20 PM ET)
Curaleaf launches $4/share takeover bid for Aurora Cannabis
Seeking Alpha News (Tue, 18-Aug 8:24 AM ET)
Aurora Cannabis Earnings Call Balances Strain And Growth
TipRanks (Mon, 17-Aug 8:22 PM ET)
Key deals this week: Workday, Diversified Energy, Aurora Cannabis, and more
Seeking Alpha News (Sat, 15-Aug 3:15 PM ET)
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.
Aurora Cannabis - Common Shares trades on the NASDAQ stock market under the symbol ACB.
As of August 19, 2026, ACB stock price climbed to $3.91 with 1,764,409 million shares trading.
ACB has a beta of 1.48, meaning it tends to be more sensitive to market movements. ACB has a correlation of 0.12 to the broad based SPY ETF.
ACB has a market cap of $242.19 million. This is considered a Small Cap stock.
Last quarter Aurora Cannabis - Common Shares reported $49 million in Revenue and -$.05 earnings per share. This fell short of revenue expectation by $-2 million and exceeded earnings estimates by $.08.
In the last 3 years, ACB traded as high as $11.50 and as low as $2.56.
The top ETF exchange traded funds that ACB belongs to (by Net Assets): MJ, YOLO, DFIC.
ACB has underperformed the market in the last year with a return of -23.6%, while SPY returned +20.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ACB shares. However, ACB has outperformed the market in the last 3 month and 2 week periods, returning +19.2% and +39.1%, while SPY returned +4.4% and -0.3%, respectively. This indicates ACB has been having a stronger performance recently.
ACB support price is $3.55 and resistance is $3.79 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACB shares will trade within this expected range on the day.